Back to search
FDAFDA · Food and drugs·Recall number D-0229-2025

Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90

Published February 26, 2025 · Recall initiated: February 4, 2025

Summary

FDA records drug Class II recall D-0229-2025, published February 26, 2025 and initiated February 4, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 1266 bottles; Lot: Lot#: BC20223A, Exp. March 31, 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

What to do

Voluntary: Firm initiated · Letter

Get an email if SILODOSIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SILODOSIN
Manufacturer
AvKARE
Distributor
USA Nationwide
Lot
Lot#: BC20223A, Exp. March 31, 2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Silodosin Capsules, 8mg, 90-count bottle, Rx only, Manufactured for: AvKare, Pulaski, TN 38478, Manufactured by: Amneal Pharmaceuticals of NY, LLC, NY 11719, NDC 42291-778-90 recalled?

Yes. FDA published recall D-0229-2025 on February 26, 2025. Reported hazard: Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SILODOSIN.